{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fcmv-risk-in-hct-recipients-ZpHUenXr","width":444,"version":"1.0","type":"rich","title":"Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/0d47054f-28b3-418a-94e4-7cada8eaca89/100847_cmv_tandem3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/926f7116-2ff2-45ec-b8d5-3a92d9f90747\" height=\"200\" width=\"100%\" title=\"Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies to effectively identify and monitor high-risk patients."}